DK662087A - 2,3-disubstituerede-isoxazolidiner, deres fremsti lling og anvendelse - Google Patents

2,3-disubstituerede-isoxazolidiner, deres fremsti lling og anvendelse

Info

Publication number
DK662087A
DK662087A DK662087A DK662087A DK662087A DK 662087 A DK662087 A DK 662087A DK 662087 A DK662087 A DK 662087A DK 662087 A DK662087 A DK 662087A DK 662087 A DK662087 A DK 662087A
Authority
DK
Denmark
Prior art keywords
isoxazolidines
disubstituted
preparation
Prior art date
Application number
DK662087A
Other languages
English (en)
Other versions
DK662087D0 (da
DK171894B1 (da
Inventor
Stephan Henke
Dietrich Brocks
Volkmar Guenzler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK662087D0 publication Critical patent/DK662087D0/da
Publication of DK662087A publication Critical patent/DK662087A/da
Application granted granted Critical
Publication of DK171894B1 publication Critical patent/DK171894B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK662087A 1986-12-17 1987-12-16 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf DK171894B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3643012 1986-12-17
DE19863643012 DE3643012A1 (de) 1986-12-17 1986-12-17 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Publications (3)

Publication Number Publication Date
DK662087D0 DK662087D0 (da) 1987-12-16
DK662087A true DK662087A (da) 1988-06-18
DK171894B1 DK171894B1 (da) 1997-08-04

Family

ID=6316346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662087A DK171894B1 (da) 1986-12-17 1987-12-16 2,3-Disubstitueret isoxazolidin-holdige di- eller tripeptider, deres fremstilling og farmaceutiske præparater deraf

Country Status (21)

Country Link
US (2) US5422342A (da)
EP (1) EP0271865B1 (da)
JP (1) JP2703912B2 (da)
KR (1) KR960010349B1 (da)
AR (1) AR246528A1 (da)
AT (1) ATE81344T1 (da)
AU (1) AU599177B2 (da)
CA (1) CA1338484C (da)
DE (2) DE3643012A1 (da)
DK (1) DK171894B1 (da)
ES (1) ES2052539T3 (da)
FI (1) FI88303C (da)
GR (1) GR3006699T3 (da)
HU (1) HU201961B (da)
IE (1) IE61034B1 (da)
IL (1) IL84841A (da)
NO (1) NO175058B (da)
NZ (1) NZ222921A (da)
PH (1) PH24746A (da)
PT (1) PT86380B (da)
ZA (1) ZA879400B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease
DE4016596A1 (de) * 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1420786A2 (en) * 2001-08-23 2004-05-26 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives
RU2416606C2 (ru) * 2004-06-17 2011-04-20 Инфинити Дискавери, Инк. Соединения и способы для ингибирования взаимодействия bcl белков с компонентами по связыванию
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4269772A (en) * 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
US4562187A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (Isoxazol-3-yl)arylmethanones, compositions and pharmaceutical use
DE3643957A1 (de) * 1986-12-22 1988-06-30 Bayer Ag Substituierte n-methylisoxazolidine

Also Published As

Publication number Publication date
IL84841A (en) 1992-07-15
US5610146A (en) 1997-03-11
FI875503A0 (fi) 1987-12-15
PT86380B (pt) 1990-11-20
HU201961B (en) 1991-01-28
GR3006699T3 (da) 1993-06-30
DE3643012A1 (de) 1988-06-30
DK662087D0 (da) 1987-12-16
FI875503A (fi) 1988-06-18
NO875263D0 (no) 1987-12-16
NO175058B (no) 1994-05-16
NZ222921A (en) 1989-08-29
PT86380A (de) 1988-01-01
EP0271865B1 (de) 1992-10-07
US5422342A (en) 1995-06-06
AR246528A1 (es) 1994-08-31
KR960010349B1 (ko) 1996-07-30
FI88303C (fi) 1993-04-26
AU8258987A (en) 1988-06-23
FI88303B (fi) 1993-01-15
ATE81344T1 (de) 1992-10-15
KR880007497A (ko) 1988-08-27
NO875263L (no) 1988-06-20
IE873418L (en) 1988-06-17
EP0271865A2 (de) 1988-06-22
DE3782149D1 (da) 1992-11-12
HUT47956A (en) 1989-04-28
AU599177B2 (en) 1990-07-12
IE61034B1 (en) 1994-09-07
CA1338484C (en) 1996-07-23
JP2703912B2 (ja) 1998-01-26
DK171894B1 (da) 1997-08-04
IL84841A0 (en) 1988-06-30
ES2052539T3 (es) 1994-07-16
ZA879400B (en) 1988-07-27
PH24746A (en) 1990-10-01
EP0271865A3 (en) 1990-02-07
NO175058C (da) 1994-08-24
JPS63165374A (ja) 1988-07-08

Similar Documents

Publication Publication Date Title
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK662087D0 (da) 2,3-disubstituerede-isoxazolidiner, deres fremsti lling og anvendelse
DK131787D0 (da) 1,1-disubstituerede cyclopropanderivater, deres fremstilling og anvendelse
DK354687D0 (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK387587D0 (da) 1,4-benzodiazepiner, deres fremstilling og anvendelse
DK633287A (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK535287A (da) Piperidin-4-yl-tetracycliske benzodiazepiner, deres fremstilling og anvendelse
DK573385A (da) 2,4-diaminopyrimidiner, deres fremstilling og anvendelse
DK453686A (da) 6,9-disubstituerede aminopuriner, deres fremstilling og anvendelse
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
DK393485A (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK213387A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK295785D0 (da) 1,8-diacyloxy-10-acyl-anthroner, deres fremstilling og anvendelse
DK217987A (da) Benzoxazolyl- og benzothiazolylaniliner, deres fremstilling og anvendelse
DK212687A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK289287D0 (da) 1-phenylalkylimidazol-4- og/eller -5-carboxamider samt deres fremstiling og anvendelse
DK388986D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
DK625287D0 (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
DK675687A (da) Substituerede n-methylisoxazolidiner, deres fremstilling og anvendelse
DK8887A (da) Substituerede 1,3,5-oxadiazin-2-oner samt deres fremstilling og anvendelse
DK538385A (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
DK126987A (da) Pyrimidoindoler, deres fremstilling og anvendelse
DK455189A (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
DK127087D0 (da) Phenylsulfonyl-pyridanaldoximer, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK